The 10-milliliter vials of Humalog and insulin lispro injection will be in short supply at wholesalers and some pharmacies, Lilly said in a statement posted online Wednesday. The company said that ...

Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

To be effective as of 1st May this year, Lispro will then be the lowest list-priced mealtime insulin available – less than the price of a Humalog vial back in 1999. On which point, Lilly is also ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

Eli Lilly and Company (NYSE ... The company’s diabetes portfolio includes key products like Humalog (insulin lispro), Trulicity (dulaglutide), Mounjaro (tirzepatide), and Zepbound (tirzepatide).

Insulin lispro protamine suspension 75% (rDNA origin), insulin lispro 25% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol. The primary activity of insulin is the regulation of glucose ...

Insulin lispro protamine suspension 50% (rDNA origin), insulin lispro 50% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol. The primary activity of insulin including Humalog Mix50/50 is ...